Table 2.
Characteristics | All patients (n = 66) | Failure (n = 48) | Success (n = 18) | P |
---|---|---|---|---|
Age, median (IQR), years | 47.0 (36.0–54.5) | 48.0 (38.0–56.0) | 40.0 (28.5–52.5) | 0.277 |
Sex, male patients, n (%) | 48 (72.7) | 38 (79.2) | 10 (55.6) | 0.108b |
Traumatic condition | ||||
Lower limb, n (%) | 32 (48.5) | 27 (56.3) | 5 (27.8) | 0.039 |
Blunt mutilation, n (%) | 64 (97.0) | 48 (72.7) | 16 (24.2) | 0.071c |
Total mutilation, n (%) | 29 (43.9) | 22 (45.8) | 7 (38.9) | 0.613 |
Platelet count, × 109/L, median (IQR)a | 123.5 (68.5–195.3) | 103.0 (60.0–178.0) | 162.5 (101.3–245.3) | 0.014 |
RBC count, × 1012/L, median (IQR)a | 3.0 (2.5–3.8) | 2.8 (2.3–3.4) | 3.3 (3.0–4.1) | 0.022 |
Albumin, g/L, median (IQR)a | 27.0 (23.3–33.4) | 25.8 (21.9–32.6) | 32.7 (29.3–35.7) | 0.002 |
Lactic acid on admission, mmol/L, median (IQR) | 2.7 (1.2–4.6) | 3.5 (1.4–4.8) | 1.4 (0.9–3.0) | 0.017 |
MESS, median (IQR) | 10.0 (9.0–11.3) | 11.0 (10.0–12.0) | 9.0 (7.0–10.0) | < 0.001 |
Treatment and outcomes, median (IQR) | ||||
Red cells suspension injected during surgery, mL | 800.0 (375.0–1600.0) | 850.0 (600.0–1750.0) | 400.0 (0.0–900.0) | 0.028 |
Hetastarch injected during surgery, mL | 1000.0 (500.0–1500.0) | 1000.0 (1000.0–1500.0) | 1000.0 (500.0–1000.0) | 0.015 |
72 h cumulative fluid balance after admission, mL | 5101.5 (2761.2–7953.8) | 5727.5 (3148.0–8589.0) | 3041.0 (351.0–4663.2) | 0.006 |
Length of hospital stay, day | 51.5 (26.8–69.0) | 57.0 (43.3–77.5) | 25.0 (18.8–39.5) | < 0.001 |
IQR interquartile range, RBC red blood cell, MESS mangled extremity severity score
aFirst laboratory findings after surgery
bYates’s correction was used
cFisher’s exact test was used